Navigation Links
New Study Demonstrates Novel Use of Metabolic Imaging to Locate Sperm in Infertile Men -- Non-Invasive Imaging Procedure May Replace Invasive Techniques such as Testicula
Date:2/4/2010

Men with no sperm in their ejaculate may no longer need invasive procedures to determine if they have sperm in their testes according to a new study published in Human Reproduction.

San Francisco, CA (Vocus) February 4, 2010 -- Men with no sperm in their ejaculate –a condition known as azoospermia —may no longer need invasive procedures to determine if they have sperm in their testes according to a new study published in Human Reproduction.

Instead, the study found that MR Spectroscopy—a simple metabolic scan that combines the use of 1H Spectroscopy with magnetic resonance imaging (MRI)—can be used to determine the likelihood of finding sperm in men with non-obstructive azoospermia (NOA).

The study’s lead author is Paul Turek, MD, former professor and endowed chair at the University of California San Francisco and founder of The Turek Clinic.

“Some men with azoospermia may still have small amounts of sperm in the testicle, but determining which of these men has retrievable sperm is challenging. This is a novel and exciting application of metabolic scanning that shows great potential to eliminate invasive biopsies and gives new hope to infertile men who wish to father children,” said Dr. Turek, a men’s reproductive health expert.

Traditional methods for evaluating if sperm exist, including testicular biopsy and microdissection are highly invasive and have only a 60 percent to 65 percent success rate. FNA Sperm Mapping, pioneered by Dr. Turek, is far less invasive, but still involves the use of fine needle aspiration to obtain tissue samples from the testes.

In contrast, MR Spectroscopy, or magnetic resonance spectroscopic imaging, is a non-invasive scan that measures metabolic activity in the testis. The study shows that the scan is as accurate as a more invasive testis biopsy in reading several abnormal patterns of sperm production typically associated with infertility and azoospermia. It also shows that testis tissue containing spermatids or sperm carry a distinct chemical signature that can be distinguished by MR Spectroscopy.

Additionally, MR Spectroscopy has the ability to evaluate testis metabolism in as many as 100 areas within the testis, significantly increasing the ability to sample for sperm well beyond any of the more invasive techniques commonly used today.

“Trust me when I say that men would rather have a non-invasive scan done than have a surgical procedure to determine whether or not they might be able to be fathers,” says Dr. Turek.

MR Spectroscopy is a non-invasive diagnostic technology that is cleared by the FDA.

About The Turek Clinic
The Turek Clinic, founded in 2008, is a men's reproductive health practice specializing in male infertility, vasectomy, vasectomy reversal, varicocele repair and other minimally invasive procedures using innovative and cutting-edge techniques. For more information, visit www.TheTurekClinic.com or Dr. Turek’s blog at http://www.TurekOnMensHealth.com/. A complete biography of Dr. Turek is available on Wikipedia at http://en.wikipedia.org/wiki/Paul_J._Turek.

Contact:
Kristen Pulsifer
Modern Health Communications, Inc.
310-913-5155

###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3568124.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. Penn study finds pro-death proteins required to regulate healthy immune function
2. New study shows promise in reducing surgical risks associated with surgical bleeding
3. Study, meta-analysis examine factors associated with death from heatstroke
4. Study suggests loss of 2 types of neurons -- not just 1 -- triggers Parkinsons symptoms
5. Study says COPD testing is not measuring up
6. Preclinical study suggests organ-transplant drug may aid in lupus fight
7. Ability to cope with stress can increase good cholesterol in older white men, study finds
8. High alcohol consumption increases stroke risk, Tulane study says
9. Mailman School of Public Health study examines link between racial discrimination and substance use
10. Pitt study finds inequality in tobacco advertising
11. Stanford study highlights cost-effective method of lowering heart disease risks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Florida (PRWEB) , ... January 23, 2017 , ... ... of the highly acclaimed series, Innovations with Ed Begley, Jr., scheduled to broadcast ... the technology behind SmartCap, which was founded in 2008 to address the limitations ...
(Date:1/23/2017)... ... January 23, 2017 , ... Wooden and plastic balance boards have been around since at ... Kumo Board is the first and only balance board to use a patent-pending ... and rigid at the same time as well as skill-level adjustable for all ages and ...
(Date:1/23/2017)... , ... January 23, 2017 , ... Sharon Kleyne, America’s ... air to educate listeners about the benefits of making new water infrastructure a number ... said, “it’s appropriate that we expect water infrastructure to become a top priority of ...
(Date:1/23/2017)... (PRWEB) , ... January 23, 2017 , ... ... for Assisted Living (IHCA/INCAL), will serve as a healthcare industry expert at the ... The panel discussion, moderated by Inside Indiana Business host Gerry Dick, will feature ...
(Date:1/23/2017)... ... January 23, 2017 , ... Moisture measurement ... the right method is paramount to success. Selecting an inappropriate measurement method can ... multiple persons use the same equipment. Rare or expensive substances are wasted and ...
Breaking Medicine News(10 mins):
(Date:1/23/2017)... 23, 2017  Delcath Systems, Inc. (NASDAQ: ... treatment of primary and metastatic liver cancers, today announced ... President and Chief Executive Officer of Delcath will be ... Markets, Thirteenth Annual Investor Conference at the Boca Raton ... , on Tuesday, January 31, 2017 at 10:30 ...
(Date:1/23/2017)... 2017 Varias proteínas clave ... y el riesgo de diálisis están ... pabetalone    Resverlogix Corp. ("Resverlogix" o "la ... un ensayo en fase 1 con sede en Nueva ... severa. Los datos demostraron unos resultados importantes en la ...
(Date:1/23/2017)... The global  anxiety disorders and depression treatment market  is expected to ... depression worldwide is anticipated to drive the market growth in the coming years. ... antidepressants in the recent years. Continue Reading ... ... ...
Breaking Medicine Technology: